Home
    Disclaimer
    5-MeO-EiPT molecular structure

    5-MeO-EiPT Stats & Data

    5meoeipt
    NPS DataHub
    MW260.38
    FormulaC16H24N2O
    CAS850032-66-5
    IUPACN-ethyl-5-methoxy-N-(1-methylethyl)-1H-indole-3-ethanamine
    SMILESCCN(CCc1cnc2ccc(OC)cc12)C(C)C
    InChIKeyVVEQXDHSGNBFLZ-UHFFFAOYSA-N
    2020/5.1 Indol-3-alkylamine; 2021/5.1 Indol-3-alkylamine; 2022/5.1 Indol-3-alkylamine
    Chemical Class Phenethylamine
    Psychoactive Class Psychedelic

    Effect Profile

    Curated + 3 Reports
    Psychedelic 3.1

    Mild visuals with low body load and headspace

    Visual Intensity×3
    4
    Headspace Depth×3
    2
    Auditory Effects×1
    0
    Body Load / Somatic Effects×1
    3

    Duration Timeline

    Bluelight
    Onset Comeup Peak Offset After Effects
    Insufflated
    1-10 minutes
    3.0-6.0 hours
    1.0-12.0 hours
    Oral
    15-45 minutes
    5.0-10.0 hours
    1.0-12.0 hours

    Community Effects

    TripSit
    Positive
    sedation

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1h Half tolerance 10d Baseline ~14d

    Experience Report Analysis

    Erowid
    3 Reports
    2014–2020 Date Range
    3 With Age Data
    4 Effects Detected

    Demographics

    Gender Distribution

    Age Distribution

    Reports Over Time

    Effect Analysis

    Erowid

    Effects aggregated from 3 experience reports (3 Erowid)

    3 Reports
    4 Effects Detected
    1 Positive
    2 Adverse
    1 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Positive Effects 1

    Stimulation 100.0% 70%

    Adverse Effects 2

    Nausea 100.0% 70%
    Muscle Tension 100.0% 70%

    Form / Preparation

    Most common forms and preparations reported

    ← Back to 5-MeO-EiPT